Correlation Between Valneva SE and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Valneva SE and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valneva SE ADR and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Valneva SE and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and Mineralys Therapeutics,.
Diversification Opportunities for Valneva SE and Mineralys Therapeutics,
-0.06 | Correlation Coefficient |
Good diversification
The 3 months correlation between Valneva and Mineralys is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Valneva SE i.e., Valneva SE and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between Valneva SE and Mineralys Therapeutics,
Given the investment horizon of 90 days Valneva SE ADR is expected to under-perform the Mineralys Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Valneva SE ADR is 1.39 times less risky than Mineralys Therapeutics,. The stock trades about -0.23 of its potential returns per unit of risk. The Mineralys Therapeutics, Common is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest 1,338 in Mineralys Therapeutics, Common on September 13, 2024 and sell it today you would lose (86.00) from holding Mineralys Therapeutics, Common or give up 6.43% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Valneva SE ADR vs. Mineralys Therapeutics, Common
Performance |
| Timeline |
| Valneva SE ADR |
| Mineralys Therapeutics, |
Valneva SE and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Valneva SE and Mineralys Therapeutics,
The main advantage of trading using opposite Valneva SE and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.| Valneva SE vs. NuCana PLC | Valneva SE vs. Sage Therapeutic | Valneva SE vs. Sellas Life Sciences | Valneva SE vs. Third Harmonic Bio |
| Mineralys Therapeutics, vs. Puma Biotechnology | Mineralys Therapeutics, vs. Iovance Biotherapeutics | Mineralys Therapeutics, vs. Sarepta Therapeutics | Mineralys Therapeutics, vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |